Шизофренија (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Шизофренија" in Serbian language version.

refsWebsite

Global rank Serbian rank

114doi.org

2^nd place

4^th place

99nih.gov

4^th place

8^th place

34archive.org

6^th place

5^th place

15worldcat.org

5^th place

12^th place

10elsevier.com

610^th place

653^rd place

7web.archive.org

1^st place

2nice.org.uk

3,258^th place

1,880^th place

2oup.com

485^th place

495^th place

2nature.com

234^th place

287^th place

2books.google.com

3^rd place

2^nd place

2who.int

195^th place

154^th place

2cochrane.org

7,609^th place

9,992^nd place

2psychiatryonline.org

4,032^nd place

2,550^th place

1mdpi.com

2,912^th place

8,753^rd place

1jamanetwork.com

2,650^th place

3,845^th place

1revmed.ch

low place

1hogrefe.com

low place

1sagepub.com

731^st place

793^rd place

1cambridge.org

305^th place

325^th place

1springer.com

274^th place

510^th place

1wiley.com

222^nd place

155^th place

1annualreviews.org

3,867^th place

3,436^th place

1hindawi.com

6,828^th place

9,104^th place

1yimg.com

low place

1emedicine.com

3,595^th place

3,106^th place

1stanleylab.org

low place

1behavenet.com

low place

6,565^th place

1dsm5.org

low place

2,943^rd place

1psychiatrictimes.com

9,815^th place

low place

1rcpsych.org

low place

8,720^th place

1academia.edu

121^st place

30^th place

1elsevierhealth.com

low place

1brown.uk.com

low place

1kluweronline.com

low place

1harvard.edu

18^th place

28^th place

academia.edu (Global: 121^st place; Serbian: 30^th place)

cambridge.academia.edu

Kirkbride, JB; Jones, PB (март 2011). „The Prevention of Schizophrenia—What Can We Learn From Eco-Epidemiology?”. Schizophrenia bulletin. 37 (2): 262—71. PMC 3044619 . PMID 20974748. doi:10.1093/schbul/sbq120. Архивирано из оригинала 24. 4. 2012. г. Приступљено 3. 6. 2014.

annualreviews.org (Global: 3,867^th place; Serbian: 3,436^th place)

Grill-Spector, Kalanit; Weiner, Kevin S.; Kay, Kendrick; Gomez, Jesse (2017-09-15). „The Functional Neuroanatomy of Human Face Perception”. Annual Review of Vision Science (на језику: енглески). 3 (1): 167—196. ISSN 2374-4642. doi:10.1146/annurev-vision-102016-061214.

archive.org (Global: 6^th place; Serbian: 5^th place)

Rosenhan, D. L. (1973). „On being sane in insane places.”. Science. 179 (4070): 250—258.
Nordgaard J, Arnfred SM, Handest P, Parnas J (јануар 2008). „The diagnostic status of first-rank symptoms”. Schizophrenia Bulletin. 34 (1): 137—54. PMC 2632385 . PMID 17562695. doi:10.1093/schbul/sbm044.
Mueser KT, Jeste DV (2008). Clinical Handbook of Schizophrenia. New York: Guilford Press. стр. 22-23. ISBN 978-1-59385-652-6.
Gregg L, Barrowclough C, Haddock G (2007). „Reasons for increased substance use in psychosis”. Clin Psychol Rev. 27 (4): 494—510. PMID 17240501. doi:10.1016/j.cpr.2006.09.004.
Henquet, C; Di Forti; Morrison, P; Kuepper, R; Murray, RM (новембар 2008). „Gene-Environment Interplay Between Cannabis and Psychosis”. Schizophrenia bulletin. 34 (6): 1111—21. PMC 2632498 . PMID 18723841. doi:10.1093/schbul/sbn108.
Ben Amar M, Potvin S (јун 2007). „Cannabis and psychosis: what is the link?”. Journal of psychoactive drugs. 39 (2): 131—42. PMID 17703707. doi:10.1080/02791072.2007.10399871.
Bentall RP, Fernyhough C, Morrison AP, Lewis S, Corcoran R (2007). „Prospects for a cognitive-developmental account of psychotic experiences”. Br J Clin Psychol. 46 (Pt 2): 155—73. PMID 17524210. doi:10.1348/014466506X123011.
Freeman D, Garety PA, Kuipers E, Fowler D, Bebbington PE, Dunn G (2007). „Acting on persecutory delusions: the importance of safety seeking”. Behav Res Ther. 45 (1): 89—99. PMID 16530161. doi:10.1016/j.brat.2006.01.014.
Insel, T. R. (2010). „Rethinking schizophrenia”. Nature. 468 (7321): 187—93. PMID 21068826. doi:10.1038/nature09552.
Cannon TD, Cornblatt B, McGorry P (2007). „The empirical status of the ultra high-risk (prodromal) research paradigm”. Schizophrenia Bulletin. 33 (3): 661—4. PMC 2526144 . PMID 17470445. doi:10.1093/schbul/sbm031.
McGrath, JJ; Lawlor, DA (1. 12. 2011). „The search for modifiable risk factors for schizophrenia”. The American Journal of Psychiatry. 168 (12): 1235—8. PMID 22193665. doi:10.1176/appi.ajp.2011.11081300.
Smith T, Weston C, Lieberman J (2010). „Schizophrenia (maintenance treatment)”. American Family Physician. 82 (4): 338—9. PMID 20704164.
Leucht, Stefan; Tardy, Magdolna; Komossa, Katja; Heres, Stephan; Kissling, Werner; Salanti, Georgia; Davis, John M. (1. 5. 2012). „Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis”. The Lancet. doi:10.1016/S0140-6736(12)60239-6.
Schultz SH, North SW, Shields CG (2007). „Schizophrenia: a review”. American Family Physician. 75 (12): 1821—9. PMID 17619525.
Dixon, L. B.; Dickerson, F.; Bellack, A. S.; et al. (2010). „The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements”. Schizophr Bull. 36 (1): 48—70. PMID 19955389. doi:10.1093/schbul/sbp115.
Lynch D, Laws KR, McKenna PJ (2010). „Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials”. Psychol Med. 40 (1): 9—24. PMID 19476688. doi:10.1017/S003329170900590X.
Ustun, T. B.; Rehm, J.; Chatterji, S.; Saxena, S.; Trotter, R.; Room, R.; Bickenbach, J. (1999). „Multiple-informant ranking of the disabling effects of different health conditions in 14 countries”. The Lancet. WHO/NIH Joint Project CAR Study Group. 354 (9173): 111—15. PMID 10408486. doi:10.1016/S0140-6736(98)07507-2.
Menezes NM, Arenovich T, Zipursky RB (2006). „A systematic review of longitudinal outcome studies of first-episode psychosis”. Psychol Med. 36 (10): 1349—62. PMID 16756689. doi:10.1017/S0033291706007951.
Cohen A, Patel V, Thara R, Gureje O (2008). „Questioning an axiom: better prognosis for schizophrenia in the developing world?”. Schizophr Bull. 34 (2): 229—44. PMC 2632419 . PMID 17905787. doi:10.1093/schbul/sbm105.
Keltner NL, Grant JS (2006). „Smoke, Smoke, Smoke That Cigarette”. Perspectives in Psychiatric Care. 42 (4): 256—261. PMID 17107571. doi:10.1111/j.1744-6163.2006.00085.x.
Kumra S, Shaw M, Merka P, Nakayama E, Augustin R (2001). „Childhood-onset schizophrenia: research update”. Canadian Journal of Psychiatry. 46 (10): 923—30. PMID 11816313.
Heinrichs, R. W. (2003). „Historical origins of schizophrenia: two early madmen and their illness”. Journal of the History of the Behavioral Sciences. 39 (4): 349—63. PMID 14601041. doi:10.1002/jhbs.10152.
Hansen RA, Atchison B (2000). Conditions in occupational therapy: effect on occupational performance. Hagerstown, MD: Lippincott Williams & Wilkins. ISBN 978-0-683-30417-6.
Wing, J. K. (1971). „International comparisons in the study of the functional psychoses”. British Medical Bulletin. 27 (1): 77—81. PMID 4926366. doi:10.1093/oxfordjournals.bmb.a070819.
Rosenhan, D. (1973). „On being sane in insane places”. Science. 179 (4070): 250—8. Bibcode:1973Sci...179..250R. PMID 4683124. doi:10.1126/science.179.4070.250.
Wilson, M. (1993). „DSM-III and the transformation of American psychiatry: a history”. American Journal of Psychiatry. 150 (3): 399—410. PMID 8434655. doi:10.1176/ajp.150.3.399.
Hayes, Jeffrey A.; Mitchell, Jeffrey C. (1994). „Mental health professionals' skepticism about multiple personality disorder”. Professional Psychology: Research and Practice. 25 (4): 410—415. doi:10.1037/0735-7028.25.4.410.
Putnam, Frank W (1994). Diagnosis and Treatment of Multiple Personality Disorder. New York: The Guilford Press. стр. 351. ISBN 978-0-89862-177-8.
Kim Y, Berrios GE (2001). „Impact of the term schizophrenia on the culture of ideograph: the Japanese experience”. Schizophr Bull. 27 (2): 181—5. PMID 11354585.
Wu, E. Q. (2005). „The economic burden of schizophrenia in the United States in 2002”. Journal of Clinical Psychiatry. 66 (9): 1122—9. PMID 16187769.
Maj, Mario & Sartorius, Norman (1999). Schizophrenia. Chichester: Wiley. стр. 292. ISBN 978-0-471-99906-5.
Bo, S; Abu-Akel,, A.; Kongerslev, M; Haahr, UH; Simonsen, E (јул 2011). „Risk factors for violence among patients with schizophrenia”. Clinical Psychology Review. 31 (5): 711—26. PMID 21497585. doi:10.1016/j.cpr.2011.03.002.
Pescosolido BA, Monahan J, Link BG, Stueve A, Kikuzawa S (1999). „The public's view of the competence, dangerousness, and need for legal coercion of persons with mental health problems”. American Journal of Public Health. 89 (9): 1339—45. PMC 1508769 . PMID 10474550. doi:10.2105/AJPH.89.9.1339.
Phelan JC, Link BG, Stueve A, Pescosolido BA (2000). „Public Conceptions of Mental Illness in 1950 and 1996: What Is Mental Illness and Is It to be Feared?”. Journal of Health and Social Behavior. 41 (2): 188—207. doi:10.2307/2676305.

behavenet.com (Global: low place; Serbian: 6,565^th place)

Association, American Psychiatric (2000). „Schizophrenia”. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Publishing, Inc. ISBN 978-0-89042-024-9. Архивирано из оригинала 11. 06. 2008. г. Приступљено 4. 7. 2008.

books.google.com (Global: 3^rd place; Serbian: 2^nd place)

Schneider, K (1959). Clinical Psychopathology (5 изд.). New York: Grune & Stratton.
Hassett 2005, стр. 6. Hassett, Anne, ур. (2005). Psychosis in the Elderly. London: Taylor and Francis. стр. 6. ISBN 978-1-84184-394-0.

brown.uk.com (Global: low place; Serbian: low place)

Medalia A, Choi J (2009). „Cognitive remediation in schizophrenia.” (PDF). Neuropsychology Rev. 19 (3): 353—364. PMID 19444614. doi:10.1007/s11065-009-9097-y.

cambridge.org (Global: 305^th place; Serbian: 325^th place)

Biedermann, Falko; Fleischhacker, W. Wolfgang (2016). „Psychotic disorders in DSM-5 and ICD-11”. CNS Spectrums (на језику: енглески). 21 (4): 349—354. ISSN 1092-8529. doi:10.1017/S1092852916000316.

cochrane.org (Global: 7,609^th place; Serbian: 9,992^nd place)

Ruddy R, Milnes D (2005). „Art therapy for schizophrenia or schizophrenia-like illnesses.”. Cochrane Database Syst Rev (4): CD003728. PMID 16235338. doi:10.1002/14651858.CD003728.pub2. Архивирано из оригинала 27. 10. 2011. г. Приступљено 03. 06. 2014.
Ruddy RA, Dent-Brown K (2007). „Drama therapy for schizophrenia or schizophrenia-like illnesses.”. Cochrane Database Syst Rev (1): CD005378. PMID 17253555. doi:10.1002/14651858.CD005378.pub2. Архивирано из оригинала 25. 08. 2011. г. Приступљено 03. 06. 2014.

doi.org (Global: 2^nd place; Serbian: 4^th place)

Stępnicki, Piotr; Kondej, Magda; Kaczor, Agnieszka A. (2018-08-20). „Current Concepts and Treatments of Schizophrenia”. Molecules (на језику: енглески). 23 (8): 2087. ISSN 1420-3049. doi:10.3390/molecules23082087.
Marshall, Max; Lewis, Shon; Lockwood, Austin; Drake, Richard; Jones, Peter; Croudace, Tim (2005-09-01). „Association Between Duration of Untreated Psychosis and Outcome in Cohorts of First-Episode Patients: A Systematic Review”. Archives of General Psychiatry (на језику: енглески). 62 (9): 975. ISSN 0003-990X. doi:10.1001/archpsyc.62.9.975.
Montagnese, Marcella; Leptourgos, Pantelis; Fernyhough, Charles; Waters, Flavie; Larøi, Frank; Jardri, Renaud; McCarthy-Jones, Simon; Thomas, Neil; Dudley, Rob (2021-01-23). „A Review of Multimodal Hallucinations: Categorization, Assessment, Theoretical Perspectives, and Clinical Recommendations”. Schizophrenia Bulletin (на језику: енглески). 47 (1): 237—248. ISSN 0586-7614. doi:10.1093/schbul/sbaa101.
Owen, Michael J; Sawa, Akira; Mortensen, Preben B (2016). „Schizophrenia”. The Lancet (на језику: енглески). 388 (10039): 86—97. doi:10.1016/S0140-6736(15)01121-6.
Klaus, Federica; Dorsaz, Orianne; Kaiser, Stefan (2018). „Symptômes négatifs de la schizophrénie – état des lieux et implications pratiques”. Revue Médicale Suisse (на језику: енглески). 14 (619): 1660—1664. ISSN 1660-9379. doi:10.53738/REVMED.2018.14.619.1660.
Bortolon, Catherine; Macgregor, Alexandra; Capdevielle, Delphine; Raffard, Stéphane (2018). „Apathy in schizophrenia: A review of neuropsychological and neuroanatomical studies”. Neuropsychologia (на језику: енглески). 118: 22—33. doi:10.1016/j.neuropsychologia.2017.09.033.
Klaus, Federica; Kaiser, Stefan; Kirschner, Matthias (2018). „Negativsymptome der Schizophrenie – ein Überblick”. Therapeutische Umschau (на језику: немачки). 75 (1): 51—56. ISSN 0040-5930. doi:10.1024/0040-5930/a000966.
Marder, Stephen R.; Kirkpatrick, Brian (2014). „Defining and measuring negative symptoms of schizophrenia in clinical trials”. European Neuropsychopharmacology (на језику: енглески). 24 (5): 737—743. doi:10.1016/j.euroneuro.2013.10.016.
Galderisi, Silvana; Mucci, Armida; Buchanan, Robert W; Arango, Celso (2018). „Negative symptoms of schizophrenia: new developments and unanswered research questions”. The Lancet Psychiatry (на језику: енглески). 5 (8): 664—677. doi:10.1016/S2215-0366(18)30050-6.
Tatsumi, Kazunori; Kirkpatrick, Brian; Strauss, Gregory P.; Opler, Mark (2020). „The brief negative symptom scale in translation: A review of psychometric properties and beyond”. European Neuropsychopharmacology (на језику: енглески). 33: 36—44. doi:10.1016/j.euroneuro.2020.01.018.
Murante, Tessa; Cohen, Carl I. (2017). „Cognitive Functioning in Older Adults With Schizophrenia”. FOCUS (на језику: енглески). 15 (1): 26—34. ISSN 1541-4094. doi:10.1176/appi.focus.20160032.
Bozikas, Vasilis P.; Andreou, Christina (2011). „Longitudinal Studies of Cognition in First Episode Psychosis: A Systematic Review of the Literature”. Australian & New Zealand Journal of Psychiatry (на језику: енглески). 45 (2): 93—108. ISSN 0004-8674. doi:10.3109/00048674.2010.541418.
Biedermann, Falko; Fleischhacker, W. Wolfgang (2016). „Psychotic disorders in DSM-5 and ICD-11”. CNS Spectrums (на језику: енглески). 21 (4): 349—354. ISSN 1092-8529. doi:10.1017/S1092852916000316.
Hashimoto, Kenji (2019). „Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings”. Current Psychiatry Reports (на језику: енглески). 21 (8). ISSN 1523-3812. doi:10.1007/s11920-019-1063-7.
Javitt, Daniel C.; Sweet, Robert A. (2015). „Auditory dysfunction in schizophrenia: integrating clinical and basic features”. Nature Reviews Neuroscience (на језику: енглески). 16 (9): 535—550. ISSN 1471-003X. doi:10.1038/nrn4002.
Goldberg, Terry E; Keefe, Richard S E; Goldman, Robert S; Robinson, Delbert G; Harvey, Philip D (2010). „Circumstances Under Which Practice Does Not Make Perfect: A Review of the Practice Effect Literature in Schizophrenia and Its Relevance to Clinical Treatment Studies”. Neuropsychopharmacology (на језику: енглески). 35 (5): 1053—1062. ISSN 0893-133X. doi:10.1038/npp.2009.211.
Green, Michael F.; Horan, William P.; Lee, Junghee (2019). „Nonsocial and social cognition in schizophrenia: current evidence and future directions”. World Psychiatry (на језику: енглески). 18 (2): 146—161. ISSN 1723-8617. doi:10.1002/wps.20624.
Kohler, C. G.; Walker, J. B.; Martin, E. A.; Healey, K. M.; Moberg, P. J. (2010-09-01). „Facial Emotion Perception in Schizophrenia: A Meta-analytic Review”. Schizophrenia Bulletin (на језику: енглески). 36 (5): 1009—1019. ISSN 0586-7614. doi:10.1093/schbul/sbn192.
Grill-Spector, Kalanit; Weiner, Kevin S.; Kay, Kendrick; Gomez, Jesse (2017-09-15). „The Functional Neuroanatomy of Human Face Perception”. Annual Review of Vision Science (на језику: енглески). 3 (1): 167—196. ISSN 2374-4642. doi:10.1146/annurev-vision-102016-061214.
Vidailhet, P. (2013). „Premier épisode psychotique, troubles cognitifs et remédiation”. L'Encéphale (на језику: француски). 39: S83—S92. doi:10.1016/S0013-7006(13)70101-5.
Fountoulakis, Konstantinos N.; Panagiotidis, Panagiotis; Kimiskidis, Vasilios; Nimatoudis, Ioannis; Gonda, Xenia (2019). „Neurological soft signs in familial and sporadic schizophrenia”. Psychiatry Research (на језику: енглески). 272: 222—229. doi:10.1016/j.psychres.2018.12.105.
Da Fonseca, D.; Fourneret, P. (2018). „Schizophrénie à début très précoce”. L'Encéphale (на језику: француски). 44 (6): S8—S11. doi:10.1016/S0013-7006(19)30071-5.
Häfner, Heinz (2019-04-16). „From Onset and Prodromal Stage to a Life-Long Course of Schizophrenia and Its Symptom Dimensions: How Sex, Age, and Other Risk Factors Influence Incidence and Course of Illness”. Psychiatry Journal (на језику: енглески). 2019: 1—15. ISSN 2314-4327. doi:10.1155/2019/9804836.
Cohen, Carl I.; Freeman, Ksenia; Ghoneim, Dina; Vengassery, Aninditha; Ghezelaiagh, Brian; Reinhardt, Michael M. (2018). „Advances in the Conceptualization and Study of Schizophrenia in Later Life”. Psychiatric Clinics of North America (на језику: енглески). 41 (1): 39—53. doi:10.1016/j.psc.2017.10.004.
Lecardeur, L.; Meunier-Cussac, S.; Dollfus, S. (2013). „Troubles cognitifs des sujets présentant un premier épisode psychotique et à haut risque de transition vers la psychose : du repérage à la prise en charge”. L'Encéphale (на језику: француски). 39: S64—S71. doi:10.1016/j.encep.2012.10.011.
Nordgaard J, Arnfred SM, Handest P, Parnas J (јануар 2008). „The diagnostic status of first-rank symptoms”. Schizophrenia Bulletin. 34 (1): 137—54. PMC 2632385 . PMID 17562695. doi:10.1093/schbul/sbm044.
Os, Jim van; Kapur, S. (август 2009). „Schizophrenia” (PDF). Lancet. 374 (9690): 635—45. PMID 19700006. doi:10.1016/S0140-6736(09)60995-8. Архивирано из оригинала (PDF) 23. 6. 2013. г. Приступљено 3. 6. 2014.
Picchioni MM, Murray RM (2007). Schizophrenia BMJ. 335 (7610): 91—5. PMC 1914490 . PMID 17626963. doi:10.1136/bmj.39227.616447.BE //www.ncbi.nlm.nih.gov/pmc/articles/PMC1914490. Недостаје или је празан параметар |title= (помоћ)
Drake RJ, Lewis SW (март 2005). „Early detection of schizophrenia”. Current Opinion in Psychiatry. 18 (2): 147—50. PMID 16639167. doi:10.1097/00001504-200503000-00007.
O'Donovan MC, Williams NM, Owen MJ (октобар 2003). „Recent advances in the genetics of schizophrenia”. Hum. Mol. Genet. 12 Spec No 2: R125—33. PMID 12952866. doi:10.1093/hmg/ddg302.
McLaren JA, Silins E, Hutchinson D, Mattick RP, Hall W (јануар 2010). „Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies”. Int. J. Drug Policy. 21 (1): 10—9. PMID 19783132. doi:10.1016/j.drugpo.2009.09.001.
O'Donovan MC, Craddock NJ, Owen MJ (јул 2009). „Genetics of psychosis; insights from views across the genome”. Hum. Genet. 126 (1): 3—12. PMID 19521722. doi:10.1007/s00439-009-0703-0.
Craddock N, Owen MJ (2010). „The Kraepelinian dichotomy - going, going... But still not gone”. The British Journal of Psychiatry. 196: 92—95. PMC 2815936 . PMID 20118450. doi:10.1192/bjp.bp.109.073429.
Crow, T. J. (јул 2008). „The 'big bang' theory of the origin of psychosis and the faculty of language”. Schizophrenia Research. 102 (1–3): 31—52. PMID 18502103. doi:10.1016/j.schres.2008.03.010.
Os, Jim van (2004). „Does the urban environment cause psychosis?”. British Journal of Psychiatry. 184 (4): 287—288. PMID 15056569. doi:10.1192/bjp.184.4.287.
Selten JP, Cantor-Graae E, Kahn RS (март 2007). „Migration and schizophrenia”. Current Opinion in Psychiatry. 20 (2): 111—115. PMID 17278906. doi:10.1097/YCO.0b013e328017f68e.
Gregg L, Barrowclough C, Haddock G (2007). „Reasons for increased substance use in psychosis”. Clin Psychol Rev. 27 (4): 494—510. PMID 17240501. doi:10.1016/j.cpr.2006.09.004.
Large M, Sharma S, Compton MT, Slade T, Nielssen O (јун 2011). „Cannabis use and earlier onset of psychosis: a systematic meta-analysis”. Arch. Gen. Psychiatry. 68 (6): 555—61. PMID 21300939. doi:10.1001/archgenpsychiatry.2011.5.
Leweke FM, Koethe D (2008). „Cannabis and psychiatric disorders: it is not only addiction”. Addict Biol. 13 (2): 264—75. PMID 18482435. doi:10.1111/j.1369-1600.2008.00106.x.
Moore, THM; Zammit, S.; Lingford-Hughes, A.; et al. (2007). „Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review”. Lancet. 370 (9584): 319—328. PMID 17662880. doi:10.1016/S0140-6736(07)61162-3.
Sewell, RA; Ranganathan, M; D'Souza,, D. C. (април 2009). „Cannabinoids and psychosis”. International review of psychiatry (Abingdon, England). 21 (2): 152—62. PMID 19367509. doi:10.1080/09540260902782802.
Henquet, C; Di Forti; Morrison, P; Kuepper, R; Murray, RM (новембар 2008). „Gene-Environment Interplay Between Cannabis and Psychosis”. Schizophrenia bulletin. 34 (6): 1111—21. PMC 2632498 . PMID 18723841. doi:10.1093/schbul/sbn108.
Ben Amar M, Potvin S (јун 2007). „Cannabis and psychosis: what is the link?”. Journal of psychoactive drugs. 39 (2): 131—42. PMID 17703707. doi:10.1080/02791072.2007.10399871.
Broome, M. R.; Woolley, J. B.; Tabraham, P.; et al. (2005). „What causes the onset of psychosis?”. Schizophr. Res. 79 (1): 23—34. PMID 16198238. doi:10.1016/j.schres.2005.02.007.
Bentall RP, Fernyhough C, Morrison AP, Lewis S, Corcoran R (2007). „Prospects for a cognitive-developmental account of psychotic experiences”. Br J Clin Psychol. 46 (Pt 2): 155—73. PMID 17524210. doi:10.1348/014466506X123011.
Kurtz, M. M. (2005). „Neurocognitive impairment across the lifespan in schizophrenia: an update”. Schizophrenia Research. 74 (1): 15—26. PMID 15694750. doi:10.1016/j.schres.2004.07.005.
Cohen AS, Docherty NM (2004). „Affective reactivity of speech and emotional experience in patients with schizophrenia”. Schizophrenia Research. 69 (1): 7—14. PMID 15145465. doi:10.1016/S0920-9964(03)00069-0.
Horan WP, Blanchard JJ (2003). „Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping”. Schizophrenia Research. 60 (2–3): 271—83. PMID 12591589. doi:10.1016/S0920-9964(02)00227-X.
Smith, B.; Fowler, D. G.; Freeman, D.; et al. (2006). „Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations”. Schizophr. Res. 86 (1–3): 181—8. PMID 16857346. doi:10.1016/j.schres.2006.06.018.
Beck, AT (2004). „A Cognitive Model of Schizophrenia”. Journal of Cognitive Psychotherapy. 18 (3): 281—88. doi:10.1891/jcop.18.3.281.65649.
Bell V, Halligan PW, Ellis HD (2006). „Explaining delusions: a cognitive perspective”. Trends in Cognitive Science. 10 (5): 219—26. PMID 16600666. doi:10.1016/j.tics.2006.03.004.
Freeman D, Garety PA, Kuipers E, Fowler D, Bebbington PE, Dunn G (2007). „Acting on persecutory delusions: the importance of safety seeking”. Behav Res Ther. 45 (1): 89—99. PMID 16530161. doi:10.1016/j.brat.2006.01.014.
Kuipers E, Garety P, Fowler D, Freeman D, Dunn G, Bebbington P (2006). „Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms”. Schizophr Bull. 32 Suppl 1: S24—31. PMC 2632539 . PMID 16885206. doi:10.1093/schbul/sbl014.
Insel, T. R. (2010). „Rethinking schizophrenia”. Nature. 468 (7321): 187—93. PMID 21068826. doi:10.1038/nature09552.
Laruelle, M.; Abi-Dargham, A.; CH, van Dyck; et al. (1996). „Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects”. Proc. Natl. Acad. Sci. U.S.A. 93 (17): 9235—40. PMC 38625 . PMID 8799184. doi:10.1073/pnas.93.17.9235.
Jones HM, Pilowsky LS (2002). „Dopamine and antipsychotic drug action revisited”. British Journal of Psychiatry. 181: 271—275. PMID 12356650. doi:10.1192/bjp.181.4.271.
Konradi C, Heckers S (2003). „Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment”. Pharmacology and Therapeutics. 97 (2): 153—79. PMID 12559388. doi:10.1016/S0163-7258(02)00328-5.
Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA (2001). „Effects of ketamine in normal and schizophrenic volunteers”. Neuropsychopharmacology. 25 (4): 455—67. PMID 11557159. doi:10.1016/S0893-133X(01)00243-3.
Coyle JT, Tsai G, Goff D (2003). „Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia”. Annals of the New York Academy of Sciences. 1003: 318—27. PMID 14684455. doi:10.1196/annals.1300.020.
Tuominen HJ, Tiihonen J, Wahlbeck K (2005). „Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis”. Schizophrenia Research. 72 (2–3): 225—34. PMID 15560967. doi:10.1016/j.schres.2004.05.005.
Jakobsen, K. D.; Frederiksen, J. N.; Hansen, T.; et al. (2005). „Reliability of clinical ICD-10 schizophrenia diagnoses”. Nordic Journal of Psychiatry. 59 (3): 209—12. PMID 16195122. doi:10.1080/08039480510027698.
Marshall M, Rathbone J (2006). „Early intervention for psychosis”. Cochrane Database Syst Rev (4): CD004718. PMID 17054213. doi:10.1002/14651858.CD004718.pub2.
de, M. B. Koning; Bloemen, O. J.; TA, van Amelsvoort; et al. (2009). „Early intervention in patients at ultra high risk of psychosis: benefits and risks”. Acta Psychiatr Scand. 119 (6): 426—42. PMID 19392813. doi:10.1111/j.1600-0447.2009.01372.x.
Cannon TD, Cornblatt B, McGorry P (2007). „The empirical status of the ultra high-risk (prodromal) research paradigm”. Schizophrenia Bulletin. 33 (3): 661—4. PMC 2526144 . PMID 17470445. doi:10.1093/schbul/sbm031.
Arseneault L, Cannon M, Witton J, Murray RM (2004). „Causal association between cannabis and psychosis: examination of the evidence”. Br J Psychiatry. 184 (2): 110—7. PMID 14754822. doi:10.1192/bjp.184.2.110.
Arendt, M; Rosenberg, R; Foldager, L; Perto, G; Munk-Jørgensen, P. (децембар 2005). „Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases”. The British journal of psychiatry : the journal of mental science. 187 (6): 510—5. PMID 16319402. doi:10.1192/bjp.187.6.510.
Kirkbride, JB; Jones, PB (март 2011). „The Prevention of Schizophrenia—What Can We Learn From Eco-Epidemiology?”. Schizophrenia bulletin. 37 (2): 262—71. PMC 3044619 . PMID 20974748. doi:10.1093/schbul/sbq120. Архивирано из оригинала 24. 4. 2012. г. Приступљено 3. 6. 2014.
McGrath, JJ; Lawlor, DA (1. 12. 2011). „The search for modifiable risk factors for schizophrenia”. The American Journal of Psychiatry. 168 (12): 1235—8. PMID 22193665. doi:10.1176/appi.ajp.2011.11081300.
Becker T, Kilian R (2006). „Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care?”. Acta Psychiatrica Scandinavica Supplement. 113 (429): 9—16. PMID 16445476. doi:10.1111/j.1600-0447.2005.00711.x.
McGurk SR, Mueser KT, Feldman K, Wolfe R, Pascaris A (2007). „Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial.”. American Journal of Psychiatry. 164 (3): 437—41. PMID 17329468. doi:10.1176/appi.ajp.164.3.437. Архивирано из оригинала 03. 03. 2007. г. Приступљено 03. 06. 2014.
Gorczynski P, Faulkner G (2010). „Exercise therapy for schizophrenia”. Cochrane Database Syst Rev (5): CD004412. PMID 20464730. doi:10.1002/14651858.CD004412.pub2.
Tandon R, Keshavan MS, Nasrallah HA (2008). „Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview” (PDF). Schizophrenia Research. 100 (1–3): 4—19. PMID 18291627. doi:10.1016/j.schres.2008.01.022.
Leucht, Stefan; Tardy, Magdolna; Komossa, Katja; Heres, Stephan; Kissling, Werner; Salanti, Georgia; Davis, John M. (1. 5. 2012). „Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis”. The Lancet. doi:10.1016/S0140-6736(12)60239-6.
Wahlbeck K, Cheine MV, Essali A (2007). „Clozapine versus typical neuroleptic medication for schizophrenia”. The Cochrane Database of Systematic Reviews. John Wiley and Sons, Ltd. (2): CD000059. PMID 10796289. doi:10.1002/14651858.CD000059.
Tandon, R.; Belmaker, R. H.; Gattaz, W. F.; et al. (2008). „World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia”. Schizophr. Res. 100 (1–3): 20—38. PMID 18243663. doi:10.1016/j.schres.2007.11.033.
Chwastiak LA, Tek C (2009). „The unchanging mortality gap for people with schizophrenia”. Lancet. 374 (9690): 590—2. PMID 19595448. doi:10.1016/S0140-6736(09)61072-2.
Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T (2004). „Neuroleptic malignant syndrome and atypical antipsychotic drugs”. Journal of Clinical Psychiatry. 65 (4): 464—70. PMID 15119907. doi:10.4088/JCP.v65n0403.
Pharoah F, Mari J, Rathbone J, Wong W (2010). „Family intervention for schizophrenia”. Cochrane Database Syst Rev. 12: CD000088. PMID 21154340. doi:10.1002/14651858.CD000088.pub3.
Medalia A, Choi J (2009). „Cognitive remediation in schizophrenia.” (PDF). Neuropsychology Rev. 19 (3): 353—364. PMID 19444614. doi:10.1007/s11065-009-9097-y.
Dixon, L. B.; Dickerson, F.; Bellack, A. S.; et al. (2010). „The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements”. Schizophr Bull. 36 (1): 48—70. PMID 19955389. doi:10.1093/schbul/sbp115.
Lynch D, Laws KR, McKenna PJ (2010). „Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials”. Psychol Med. 40 (1): 9—24. PMID 19476688. doi:10.1017/S003329170900590X.
Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C (2004). „Cognitive behaviour therapy for schizophrenia”. Cochrane Database Syst Rev (4): CD000524. PMID 15495000. doi:10.1002/14651858.CD000524.pub2.
Ruddy R, Milnes D (2005). „Art therapy for schizophrenia or schizophrenia-like illnesses.”. Cochrane Database Syst Rev (4): CD003728. PMID 16235338. doi:10.1002/14651858.CD003728.pub2. Архивирано из оригинала 27. 10. 2011. г. Приступљено 03. 06. 2014.
Ruddy RA, Dent-Brown K (2007). „Drama therapy for schizophrenia or schizophrenia-like illnesses.”. Cochrane Database Syst Rev (1): CD005378. PMID 17253555. doi:10.1002/14651858.CD005378.pub2. Архивирано из оригинала 25. 08. 2011. г. Приступљено 03. 06. 2014.
Saha S, Chant D, McGrath J (2007). „A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?”. Arch. Gen. Psychiatry. 64 (10): 1123—31. PMID 17909124. doi:10.1001/archpsyc.64.10.1123.
Ustun, T. B.; Rehm, J.; Chatterji, S.; Saxena, S.; Trotter, R.; Room, R.; Bickenbach, J. (1999). „Multiple-informant ranking of the disabling effects of different health conditions in 14 countries”. The Lancet. WHO/NIH Joint Project CAR Study Group. 354 (9173): 111—15. PMID 10408486. doi:10.1016/S0140-6736(98)07507-2.
Warner, R. (2009). „Recovery from schizophrenia and the recovery model”. Curr Opin Psychiatry. 22 (4): 374—80. PMID 19417668. doi:10.1097/YCO.0b013e32832c920b.
Menezes NM, Arenovich T, Zipursky RB (2006). „A systematic review of longitudinal outcome studies of first-episode psychosis”. Psychol Med. 36 (10): 1349—62. PMID 16756689. doi:10.1017/S0033291706007951.
Isaac M, Chand P, Murthy P (2007). „Schizophrenia outcome measures in the wider international community”. Br J Psychiatry Suppl. 50: s71—7. PMID 18019048. doi:10.1192/bjp.191.50.s71.
Cohen A, Patel V, Thara R, Gureje O (2008). „Questioning an axiom: better prognosis for schizophrenia in the developing world?”. Schizophr Bull. 34 (2): 229—44. PMC 2632419 . PMID 17905787. doi:10.1093/schbul/sbm105.
Burns J. (2009). „Dispelling a myth: developing world poverty, inequality, violence and social fragmentation are not good for outcome in schizophrenia”. Afr J Psychiatry (Johannesbg). 12 (3): 200—5. PMID 19894340. doi:10.4314/ajpsy.v12i3.48494.
Palmer BA, Pankratz VS, Bostwick JM (2005). „The lifetime risk of suicide in schizophrenia: a reexamination”. Archives of General Psychiatry. 62 (3): 247—53. PMID 15753237. doi:10.1001/archpsyc.62.3.247.
Carlborg A, Winnerbäck K, Jönsson EG, Jokinen J, Nordström P (2010). „Suicide in schizophrenia”. Expert Rev Neurother. 10 (7): 1153—64. PMID 20586695. doi:10.1586/ern.10.82.
De Leon J, Diaz FJ (2005). „A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors”. Schizophrenia Research. 76 (2–3): 135—57. PMID 15949648. doi:10.1016/j.schres.2005.02.010.
Keltner NL, Grant JS (2006). „Smoke, Smoke, Smoke That Cigarette”. Perspectives in Psychiatric Care. 42 (4): 256—261. PMID 17107571. doi:10.1111/j.1744-6163.2006.00085.x.
Castle D, Wessely S, Der G, Murray RM (1991). „The incidence of operationally defined schizophrenia in Camberwell, 1965–84”. The British Journal of Psychiatry. 159: 790—4. PMID 1790446. doi:10.1192/bjp.159.6.790.
Jablensky, Sartorius & Ernberg 1992, стр. 1–97 Jablensky, A.; Sartorius, N.; Ernberg, G.; et al. (1992). „Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study”. Psychological Medicine Monograph Supplement. 20: 1—97. PMID 1565705. doi:10.1017/S0264180100000904.
Kirkbride, J. B.; Fearon, P.; Morgan, C.; et al. (2006). „Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study”. Archives of General Psychiatry. 63 (3): 250—8. PMID 16520429. doi:10.1001/archpsyc.63.3.250.
Kirkbride, J. B.; Fearon, P.; Morgan, C.; et al. (2007). „Neighbourhood variation in the incidence of psychotic disorders in Southeast London”. Social Psychiatry and Psychiatric Epidemiology. 42 (6): 438—45. PMID 17473901. doi:10.1007/s00127-007-0193-0.
Heinrichs, R. W. (2003). „Historical origins of schizophrenia: two early madmen and their illness”. Journal of the History of the Behavioral Sciences. 39 (4): 349—63. PMID 14601041. doi:10.1002/jhbs.10152.
Kuhn, R. (2004). tr. Cahn CH. „Eugen Bleuler's concepts of psychopathology”. History of Psychiatry. 15 (3): 361—6. PMID 15386868. doi:10.1177/0957154X04044603.
Stotz-Ingenlath G (2000). „Epistemological aspects of Eugen Bleuler's conception of schizophrenia in 1911” (PDF). Medicine, Health Care and Philosophy. 3 (2): 153—9. PMID 11079343. doi:10.1023/A:1009919309015.
Turner, T. (2007). „Unlocking psychosis”. British Medical Journal. 334 (suppl): s7. PMID 17204765. doi:10.1136/bmj.39034.609074.94.
Wing, J. K. (1971). „International comparisons in the study of the functional psychoses”. British Medical Bulletin. 27 (1): 77—81. PMID 4926366. doi:10.1093/oxfordjournals.bmb.a070819.
Rosenhan, D. (1973). „On being sane in insane places”. Science. 179 (4070): 250—8. Bibcode:1973Sci...179..250R. PMID 4683124. doi:10.1126/science.179.4070.250.
Wilson, M. (1993). „DSM-III and the transformation of American psychiatry: a history”. American Journal of Psychiatry. 150 (3): 399—410. PMID 8434655. doi:10.1176/ajp.150.3.399.
Stotz-Ingenlath G (2000). „Epistemological aspects of Eugen Bleuler's conception of schizophrenia in 1911”. Med Health Care Philos. 3 (2): 153—159. PMID 11079343. doi:10.1023/A:1009919309015.
Hayes, Jeffrey A.; Mitchell, Jeffrey C. (1994). „Mental health professionals' skepticism about multiple personality disorder”. Professional Psychology: Research and Practice. 25 (4): 410—415. doi:10.1037/0735-7028.25.4.410.
Maniglio, R (март 2009). „Severe mental illness and criminal victimization: a systematic review”. Acta Psychiatrica Scandinavica. 119 (3): 180—91. PMID 19016668. doi:10.1111/j.1600-0447.2008.01300.x.
Fazel, S; Gulati, G; Linsell, L; Geddes, JR; Grann, M (август 2009). McGrath, John, ур. „Schizophrenia and Violence: Systematic Review and Meta-Analysis”. PLoS medicine. 6 (8): e1000120. PMC 2718581 . PMID 19668362. doi:10.1371/journal.pmed.1000120.
Large, M; Smith, G; Nielssen, O. (јул 2009). „The relationship between the rate of homicide by those with schizophrenia and the overall homicide rate: a systematic review and meta-analysis”. Schizophrenia research. 112 (1–3): 123—9. PMID 19457644. doi:10.1016/j.schres.2009.04.004.
Bo, S; Abu-Akel,, A.; Kongerslev, M; Haahr, UH; Simonsen, E (јул 2011). „Risk factors for violence among patients with schizophrenia”. Clinical Psychology Review. 31 (5): 711—26. PMID 21497585. doi:10.1016/j.cpr.2011.03.002.
Pescosolido BA, Monahan J, Link BG, Stueve A, Kikuzawa S (1999). „The public's view of the competence, dangerousness, and need for legal coercion of persons with mental health problems”. American Journal of Public Health. 89 (9): 1339—45. PMC 1508769 . PMID 10474550. doi:10.2105/AJPH.89.9.1339.
Phelan JC, Link BG, Stueve A, Pescosolido BA (2000). „Public Conceptions of Mental Illness in 1950 and 1996: What Is Mental Illness and Is It to be Feared?”. Journal of Health and Social Behavior. 41 (2): 188—207. doi:10.2307/2676305.

dsm5.org (Global: low place; Serbian: 2,943^rd place)

American Psychiatric Association DSM-5 Work Groups (2010)„Proposed Revisions –Schizophrenia and Other Psychotic Disorders”. Приступљено 17. 2. 2010.

elsevier.com (Global: 610^th place; Serbian: 653^rd place)

linkinghub.elsevier.com

Owen, Michael J; Sawa, Akira; Mortensen, Preben B (2016). „Schizophrenia”. The Lancet (на језику: енглески). 388 (10039): 86—97. doi:10.1016/S0140-6736(15)01121-6.
Bortolon, Catherine; Macgregor, Alexandra; Capdevielle, Delphine; Raffard, Stéphane (2018). „Apathy in schizophrenia: A review of neuropsychological and neuroanatomical studies”. Neuropsychologia (на језику: енглески). 118: 22—33. doi:10.1016/j.neuropsychologia.2017.09.033.
Marder, Stephen R.; Kirkpatrick, Brian (2014). „Defining and measuring negative symptoms of schizophrenia in clinical trials”. European Neuropsychopharmacology (на језику: енглески). 24 (5): 737—743. doi:10.1016/j.euroneuro.2013.10.016.
Galderisi, Silvana; Mucci, Armida; Buchanan, Robert W; Arango, Celso (2018). „Negative symptoms of schizophrenia: new developments and unanswered research questions”. The Lancet Psychiatry (на језику: енглески). 5 (8): 664—677. doi:10.1016/S2215-0366(18)30050-6.
Tatsumi, Kazunori; Kirkpatrick, Brian; Strauss, Gregory P.; Opler, Mark (2020). „The brief negative symptom scale in translation: A review of psychometric properties and beyond”. European Neuropsychopharmacology (на језику: енглески). 33: 36—44. doi:10.1016/j.euroneuro.2020.01.018.
Vidailhet, P. (2013). „Premier épisode psychotique, troubles cognitifs et remédiation”. L'Encéphale (на језику: француски). 39: S83—S92. doi:10.1016/S0013-7006(13)70101-5.
Fountoulakis, Konstantinos N.; Panagiotidis, Panagiotis; Kimiskidis, Vasilios; Nimatoudis, Ioannis; Gonda, Xenia (2019). „Neurological soft signs in familial and sporadic schizophrenia”. Psychiatry Research (на језику: енглески). 272: 222—229. doi:10.1016/j.psychres.2018.12.105.
Da Fonseca, D.; Fourneret, P. (2018). „Schizophrénie à début très précoce”. L'Encéphale (на језику: француски). 44 (6): S8—S11. doi:10.1016/S0013-7006(19)30071-5.
Cohen, Carl I.; Freeman, Ksenia; Ghoneim, Dina; Vengassery, Aninditha; Ghezelaiagh, Brian; Reinhardt, Michael M. (2018). „Advances in the Conceptualization and Study of Schizophrenia in Later Life”. Psychiatric Clinics of North America (на језику: енглески). 41 (1): 39—53. doi:10.1016/j.psc.2017.10.004.
Lecardeur, L.; Meunier-Cussac, S.; Dollfus, S. (2013). „Troubles cognitifs des sujets présentant un premier épisode psychotique et à haut risque de transition vers la psychose : du repérage à la prise en charge”. L'Encéphale (на језику: француски). 39: S64—S71. doi:10.1016/j.encep.2012.10.011.

elsevierhealth.com (Global: low place; Serbian: low place)

download.journals.elsevierhealth.com

Tandon R, Keshavan MS, Nasrallah HA (2008). „Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview” (PDF). Schizophrenia Research. 100 (1–3): 4—19. PMID 18291627. doi:10.1016/j.schres.2008.01.022.

emedicine.com (Global: 3,595^th place; Serbian: 3,106^th place)

Larson, Michael (30. 3. 2006). „Alcohol-Related Psychosis”. eMedicine. WebMD. Приступљено 27. 9. 2006.

harvard.edu (Global: 18^th place; Serbian: 28^th place)

adsabs.harvard.edu

Rosenhan, D. (1973). „On being sane in insane places”. Science. 179 (4070): 250—8. Bibcode:1973Sci...179..250R. PMID 4683124. doi:10.1126/science.179.4070.250.

hindawi.com (Global: 6,828^th place; Serbian: 9,104^th place)

Häfner, Heinz (2019-04-16). „From Onset and Prodromal Stage to a Life-Long Course of Schizophrenia and Its Symptom Dimensions: How Sex, Age, and Other Risk Factors Influence Incidence and Course of Illness”. Psychiatry Journal (на језику: енглески). 2019: 1—15. ISSN 2314-4327. doi:10.1155/2019/9804836.

hogrefe.com (Global: low place; Serbian: low place)

econtent.hogrefe.com

Klaus, Federica; Kaiser, Stefan; Kirschner, Matthias (2018). „Negativsymptome der Schizophrenie – ein Überblick”. Therapeutische Umschau (на језику: немачки). 75 (1): 51—56. ISSN 0040-5930. doi:10.1024/0040-5930/a000966.

jamanetwork.com (Global: 2,650^th place; Serbian: 3,845^th place)

archpsyc.jamanetwork.com

Marshall, Max; Lewis, Shon; Lockwood, Austin; Drake, Richard; Jones, Peter; Croudace, Tim (2005-09-01). „Association Between Duration of Untreated Psychosis and Outcome in Cohorts of First-Episode Patients: A Systematic Review”. Archives of General Psychiatry (на језику: енглески). 62 (9): 975. ISSN 0003-990X. doi:10.1001/archpsyc.62.9.975.

kluweronline.com (Global: low place; Serbian: low place)

Stotz-Ingenlath G (2000). „Epistemological aspects of Eugen Bleuler's conception of schizophrenia in 1911” (PDF). Medicine, Health Care and Philosophy. 3 (2): 153—9. PMID 11079343. doi:10.1023/A:1009919309015.

mdpi.com (Global: 2,912^th place; Serbian: 8,753^rd place)

Stępnicki, Piotr; Kondej, Magda; Kaczor, Agnieszka A. (2018-08-20). „Current Concepts and Treatments of Schizophrenia”. Molecules (на језику: енглески). 23 (8): 2087. ISSN 1420-3049. doi:10.3390/molecules23082087.

nature.com (Global: 234^th place; Serbian: 287^th place)

Javitt, Daniel C.; Sweet, Robert A. (2015). „Auditory dysfunction in schizophrenia: integrating clinical and basic features”. Nature Reviews Neuroscience (на језику: енглески). 16 (9): 535—550. ISSN 1471-003X. doi:10.1038/nrn4002.
Goldberg, Terry E; Keefe, Richard S E; Goldman, Robert S; Robinson, Delbert G; Harvey, Philip D (2010). „Circumstances Under Which Practice Does Not Make Perfect: A Review of the Practice Effect Literature in Schizophrenia and Its Relevance to Clinical Treatment Studies”. Neuropsychopharmacology (на језику: енглески). 35 (5): 1053—1062. ISSN 0893-133X. doi:10.1038/npp.2009.211.

nice.org.uk (Global: 3,258^th place; Serbian: 1,880^th place)

„"Psychosis and schizophrenia in adults: treatment and management"” (PDF). март 2014. стр. 4—34. Архивирано из оригинала (PDF) 20. 04. 2014. г. (PDF). National Institute for Health and Care Excellence (NICE).. Archived from the original (PDF) on 20 April 2014.
National Collaborating Centre for Mental Health (25. 3. 2009). „Schizophrenia: Full national clinical guideline on core interventions in primary and secondary care” (PDF). Gaskell and the British Psychological Society. Приступљено 25. 11. 2009.

nih.gov (Global: 4^th place; Serbian: 8^th place)

ncbi.nlm.nih.gov

Batinic, B. (јун 2019). „Cognitive Models of Positive and Negative Symptoms of Schizophrenia and Implications for Treatment”. Psychiatr Danub. 31 (Suppl 2): 181—184. PMID 31158119.
Nordgaard J, Arnfred SM, Handest P, Parnas J (јануар 2008). „The diagnostic status of first-rank symptoms”. Schizophrenia Bulletin. 34 (1): 137—54. PMC 2632385 . PMID 17562695. doi:10.1093/schbul/sbm044.
Os, Jim van; Kapur, S. (август 2009). „Schizophrenia” (PDF). Lancet. 374 (9690): 635—45. PMID 19700006. doi:10.1016/S0140-6736(09)60995-8. Архивирано из оригинала (PDF) 23. 6. 2013. г. Приступљено 3. 6. 2014.
Picchioni MM, Murray RM (2007). Schizophrenia BMJ. 335 (7610): 91—5. PMC 1914490 . PMID 17626963. doi:10.1136/bmj.39227.616447.BE //www.ncbi.nlm.nih.gov/pmc/articles/PMC1914490. Недостаје или је празан параметар |title= (помоћ)
Drake RJ, Lewis SW (март 2005). „Early detection of schizophrenia”. Current Opinion in Psychiatry. 18 (2): 147—50. PMID 16639167. doi:10.1097/00001504-200503000-00007.
O'Donovan MC, Williams NM, Owen MJ (октобар 2003). „Recent advances in the genetics of schizophrenia”. Hum. Mol. Genet. 12 Spec No 2: R125—33. PMID 12952866. doi:10.1093/hmg/ddg302.
McLaren JA, Silins E, Hutchinson D, Mattick RP, Hall W (јануар 2010). „Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies”. Int. J. Drug Policy. 21 (1): 10—9. PMID 19783132. doi:10.1016/j.drugpo.2009.09.001.
O'Donovan MC, Craddock NJ, Owen MJ (јул 2009). „Genetics of psychosis; insights from views across the genome”. Hum. Genet. 126 (1): 3—12. PMID 19521722. doi:10.1007/s00439-009-0703-0.
Craddock N, Owen MJ (2010). „The Kraepelinian dichotomy - going, going... But still not gone”. The British Journal of Psychiatry. 196: 92—95. PMC 2815936 . PMID 20118450. doi:10.1192/bjp.bp.109.073429.
Crow, T. J. (јул 2008). „The 'big bang' theory of the origin of psychosis and the faculty of language”. Schizophrenia Research. 102 (1–3): 31—52. PMID 18502103. doi:10.1016/j.schres.2008.03.010.
Os, Jim van (2004). „Does the urban environment cause psychosis?”. British Journal of Psychiatry. 184 (4): 287—288. PMID 15056569. doi:10.1192/bjp.184.4.287.
Selten JP, Cantor-Graae E, Kahn RS (март 2007). „Migration and schizophrenia”. Current Opinion in Psychiatry. 20 (2): 111—115. PMID 17278906. doi:10.1097/YCO.0b013e328017f68e.
Gregg L, Barrowclough C, Haddock G (2007). „Reasons for increased substance use in psychosis”. Clin Psychol Rev. 27 (4): 494—510. PMID 17240501. doi:10.1016/j.cpr.2006.09.004.
Large M, Sharma S, Compton MT, Slade T, Nielssen O (јун 2011). „Cannabis use and earlier onset of psychosis: a systematic meta-analysis”. Arch. Gen. Psychiatry. 68 (6): 555—61. PMID 21300939. doi:10.1001/archgenpsychiatry.2011.5.
Leweke FM, Koethe D (2008). „Cannabis and psychiatric disorders: it is not only addiction”. Addict Biol. 13 (2): 264—75. PMID 18482435. doi:10.1111/j.1369-1600.2008.00106.x.
Moore, THM; Zammit, S.; Lingford-Hughes, A.; et al. (2007). „Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review”. Lancet. 370 (9584): 319—328. PMID 17662880. doi:10.1016/S0140-6736(07)61162-3.
Sewell, RA; Ranganathan, M; D'Souza,, D. C. (април 2009). „Cannabinoids and psychosis”. International review of psychiatry (Abingdon, England). 21 (2): 152—62. PMID 19367509. doi:10.1080/09540260902782802.
Henquet, C; Di Forti; Morrison, P; Kuepper, R; Murray, RM (новембар 2008). „Gene-Environment Interplay Between Cannabis and Psychosis”. Schizophrenia bulletin. 34 (6): 1111—21. PMC 2632498 . PMID 18723841. doi:10.1093/schbul/sbn108.
Ben Amar M, Potvin S (јун 2007). „Cannabis and psychosis: what is the link?”. Journal of psychoactive drugs. 39 (2): 131—42. PMID 17703707. doi:10.1080/02791072.2007.10399871.
Sagud, M; Mihaljević-Peles,, A.; Mück-Seler,, D.; Pivac, N; Vuksan-Cusa, B.; Brataljenović, T; Jakovljević, M. (септембар 2009). „Smoking and schizophrenia”. Psychiatria Danubina. 21 (3): 371—5. PMID 19794359.
Yolken R. (2004). „Viruses and schizophrenia: a focus on herpes simplex virus.”. Herpes. 11 (Suppl 2): 83A—88A. PMID 15319094.
Broome, M. R.; Woolley, J. B.; Tabraham, P.; et al. (2005). „What causes the onset of psychosis?”. Schizophr. Res. 79 (1): 23—34. PMID 16198238. doi:10.1016/j.schres.2005.02.007.
Bentall RP, Fernyhough C, Morrison AP, Lewis S, Corcoran R (2007). „Prospects for a cognitive-developmental account of psychotic experiences”. Br J Clin Psychol. 46 (Pt 2): 155—73. PMID 17524210. doi:10.1348/014466506X123011.
Kurtz, M. M. (2005). „Neurocognitive impairment across the lifespan in schizophrenia: an update”. Schizophrenia Research. 74 (1): 15—26. PMID 15694750. doi:10.1016/j.schres.2004.07.005.
Cohen AS, Docherty NM (2004). „Affective reactivity of speech and emotional experience in patients with schizophrenia”. Schizophrenia Research. 69 (1): 7—14. PMID 15145465. doi:10.1016/S0920-9964(03)00069-0.
Horan WP, Blanchard JJ (2003). „Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping”. Schizophrenia Research. 60 (2–3): 271—83. PMID 12591589. doi:10.1016/S0920-9964(02)00227-X.
Smith, B.; Fowler, D. G.; Freeman, D.; et al. (2006). „Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations”. Schizophr. Res. 86 (1–3): 181—8. PMID 16857346. doi:10.1016/j.schres.2006.06.018.
Bell V, Halligan PW, Ellis HD (2006). „Explaining delusions: a cognitive perspective”. Trends in Cognitive Science. 10 (5): 219—26. PMID 16600666. doi:10.1016/j.tics.2006.03.004.
Freeman D, Garety PA, Kuipers E, Fowler D, Bebbington PE, Dunn G (2007). „Acting on persecutory delusions: the importance of safety seeking”. Behav Res Ther. 45 (1): 89—99. PMID 16530161. doi:10.1016/j.brat.2006.01.014.
Kuipers E, Garety P, Fowler D, Freeman D, Dunn G, Bebbington P (2006). „Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms”. Schizophr Bull. 32 Suppl 1: S24—31. PMC 2632539 . PMID 16885206. doi:10.1093/schbul/sbl014.
Green, M. F. (2006). „Cognitive impairment and functional outcome in schizophrenia and bipolar disorder”. Journal of Clinical Psychiatry. 67 (Suppl 9): 3—8. PMID 16965182.
Insel, T. R. (2010). „Rethinking schizophrenia”. Nature. 468 (7321): 187—93. PMID 21068826. doi:10.1038/nature09552.
Laruelle, M.; Abi-Dargham, A.; CH, van Dyck; et al. (1996). „Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects”. Proc. Natl. Acad. Sci. U.S.A. 93 (17): 9235—40. PMC 38625 . PMID 8799184. doi:10.1073/pnas.93.17.9235.
Jones HM, Pilowsky LS (2002). „Dopamine and antipsychotic drug action revisited”. British Journal of Psychiatry. 181: 271—275. PMID 12356650. doi:10.1192/bjp.181.4.271.
Konradi C, Heckers S (2003). „Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment”. Pharmacology and Therapeutics. 97 (2): 153—79. PMID 12559388. doi:10.1016/S0163-7258(02)00328-5.
Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA (2001). „Effects of ketamine in normal and schizophrenic volunteers”. Neuropsychopharmacology. 25 (4): 455—67. PMID 11557159. doi:10.1016/S0893-133X(01)00243-3.
Coyle JT, Tsai G, Goff D (2003). „Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia”. Annals of the New York Academy of Sciences. 1003: 318—27. PMID 14684455. doi:10.1196/annals.1300.020.
Tuominen HJ, Tiihonen J, Wahlbeck K (2005). „Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis”. Schizophrenia Research. 72 (2–3): 225—34. PMID 15560967. doi:10.1016/j.schres.2004.05.005.
Jakobsen, K. D.; Frederiksen, J. N.; Hansen, T.; et al. (2005). „Reliability of clinical ICD-10 schizophrenia diagnoses”. Nordic Journal of Psychiatry. 59 (3): 209—12. PMID 16195122. doi:10.1080/08039480510027698.
McGlashan, T. H. (1987). „Testing DSM-III symptom criteria for schizotypal and borderline personality disorders”. Archives of General Psychiatry. 44 (2): 143—8. PMID 3813809.
Marshall M, Rathbone J (2006). „Early intervention for psychosis”. Cochrane Database Syst Rev (4): CD004718. PMID 17054213. doi:10.1002/14651858.CD004718.pub2.
de, M. B. Koning; Bloemen, O. J.; TA, van Amelsvoort; et al. (2009). „Early intervention in patients at ultra high risk of psychosis: benefits and risks”. Acta Psychiatr Scand. 119 (6): 426—42. PMID 19392813. doi:10.1111/j.1600-0447.2009.01372.x.
Cannon TD, Cornblatt B, McGorry P (2007). „The empirical status of the ultra high-risk (prodromal) research paradigm”. Schizophrenia Bulletin. 33 (3): 661—4. PMC 2526144 . PMID 17470445. doi:10.1093/schbul/sbm031.
Arseneault L, Cannon M, Witton J, Murray RM (2004). „Causal association between cannabis and psychosis: examination of the evidence”. Br J Psychiatry. 184 (2): 110—7. PMID 14754822. doi:10.1192/bjp.184.2.110.
Arendt, M; Rosenberg, R; Foldager, L; Perto, G; Munk-Jørgensen, P. (децембар 2005). „Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases”. The British journal of psychiatry : the journal of mental science. 187 (6): 510—5. PMID 16319402. doi:10.1192/bjp.187.6.510.
Kirkbride, JB; Jones, PB (март 2011). „The Prevention of Schizophrenia—What Can We Learn From Eco-Epidemiology?”. Schizophrenia bulletin. 37 (2): 262—71. PMC 3044619 . PMID 20974748. doi:10.1093/schbul/sbq120. Архивирано из оригинала 24. 4. 2012. г. Приступљено 3. 6. 2014.
McGrath, JJ; Lawlor, DA (1. 12. 2011). „The search for modifiable risk factors for schizophrenia”. The American Journal of Psychiatry. 168 (12): 1235—8. PMID 22193665. doi:10.1176/appi.ajp.2011.11081300.
Becker T, Kilian R (2006). „Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care?”. Acta Psychiatrica Scandinavica Supplement. 113 (429): 9—16. PMID 16445476. doi:10.1111/j.1600-0447.2005.00711.x.
McGurk SR, Mueser KT, Feldman K, Wolfe R, Pascaris A (2007). „Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial.”. American Journal of Psychiatry. 164 (3): 437—41. PMID 17329468. doi:10.1176/appi.ajp.164.3.437. Архивирано из оригинала 03. 03. 2007. г. Приступљено 03. 06. 2014.
Gorczynski P, Faulkner G (2010). „Exercise therapy for schizophrenia”. Cochrane Database Syst Rev (5): CD004412. PMID 20464730. doi:10.1002/14651858.CD004412.pub2.
Smith T, Weston C, Lieberman J (2010). „Schizophrenia (maintenance treatment)”. American Family Physician. 82 (4): 338—9. PMID 20704164.
Tandon R, Keshavan MS, Nasrallah HA (2008). „Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview” (PDF). Schizophrenia Research. 100 (1–3): 4—19. PMID 18291627. doi:10.1016/j.schres.2008.01.022.
Kane JM, Correll CU (2010). „Pharmacologic treatment of schizophrenia”. Dialogues Clin Neurosci. 12 (3): 345—57. PMID 20954430.
Schultz SH, North SW, Shields CG (2007). „Schizophrenia: a review”. American Family Physician. 75 (12): 1821—9. PMID 17619525.
Wahlbeck K, Cheine MV, Essali A (2007). „Clozapine versus typical neuroleptic medication for schizophrenia”. The Cochrane Database of Systematic Reviews. John Wiley and Sons, Ltd. (2): CD000059. PMID 10796289. doi:10.1002/14651858.CD000059.
Tandon, R.; Belmaker, R. H.; Gattaz, W. F.; et al. (2008). „World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia”. Schizophr. Res. 100 (1–3): 20—38. PMID 18243663. doi:10.1016/j.schres.2007.11.033.
Chwastiak LA, Tek C (2009). „The unchanging mortality gap for people with schizophrenia”. Lancet. 374 (9690): 590—2. PMID 19595448. doi:10.1016/S0140-6736(09)61072-2.
Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T (2004). „Neuroleptic malignant syndrome and atypical antipsychotic drugs”. Journal of Clinical Psychiatry. 65 (4): 464—70. PMID 15119907. doi:10.4088/JCP.v65n0403.
McEvoy, J. P. (2006). „Risks versus benefits of different types of long-acting injectable antipsychotics”. Journal of Clinical Psychiatry. 67 Suppl 5: 15—8. PMID 16822092.
Pharoah F, Mari J, Rathbone J, Wong W (2010). „Family intervention for schizophrenia”. Cochrane Database Syst Rev. 12: CD000088. PMID 21154340. doi:10.1002/14651858.CD000088.pub3.
Medalia A, Choi J (2009). „Cognitive remediation in schizophrenia.” (PDF). Neuropsychology Rev. 19 (3): 353—364. PMID 19444614. doi:10.1007/s11065-009-9097-y.
Dixon, L. B.; Dickerson, F.; Bellack, A. S.; et al. (2010). „The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements”. Schizophr Bull. 36 (1): 48—70. PMID 19955389. doi:10.1093/schbul/sbp115.
Lynch D, Laws KR, McKenna PJ (2010). „Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials”. Psychol Med. 40 (1): 9—24. PMID 19476688. doi:10.1017/S003329170900590X.
Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C (2004). „Cognitive behaviour therapy for schizophrenia”. Cochrane Database Syst Rev (4): CD000524. PMID 15495000. doi:10.1002/14651858.CD000524.pub2.
Ruddy R, Milnes D (2005). „Art therapy for schizophrenia or schizophrenia-like illnesses.”. Cochrane Database Syst Rev (4): CD003728. PMID 16235338. doi:10.1002/14651858.CD003728.pub2. Архивирано из оригинала 27. 10. 2011. г. Приступљено 03. 06. 2014.
Ruddy RA, Dent-Brown K (2007). „Drama therapy for schizophrenia or schizophrenia-like illnesses.”. Cochrane Database Syst Rev (1): CD005378. PMID 17253555. doi:10.1002/14651858.CD005378.pub2. Архивирано из оригинала 25. 08. 2011. г. Приступљено 03. 06. 2014.
Saha S, Chant D, McGrath J (2007). „A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?”. Arch. Gen. Psychiatry. 64 (10): 1123—31. PMID 17909124. doi:10.1001/archpsyc.64.10.1123.
Ustun, T. B.; Rehm, J.; Chatterji, S.; Saxena, S.; Trotter, R.; Room, R.; Bickenbach, J. (1999). „Multiple-informant ranking of the disabling effects of different health conditions in 14 countries”. The Lancet. WHO/NIH Joint Project CAR Study Group. 354 (9173): 111—15. PMID 10408486. doi:10.1016/S0140-6736(98)07507-2.
Warner, R. (2009). „Recovery from schizophrenia and the recovery model”. Curr Opin Psychiatry. 22 (4): 374—80. PMID 19417668. doi:10.1097/YCO.0b013e32832c920b.
Menezes NM, Arenovich T, Zipursky RB (2006). „A systematic review of longitudinal outcome studies of first-episode psychosis”. Psychol Med. 36 (10): 1349—62. PMID 16756689. doi:10.1017/S0033291706007951.
Isaac M, Chand P, Murthy P (2007). „Schizophrenia outcome measures in the wider international community”. Br J Psychiatry Suppl. 50: s71—7. PMID 18019048. doi:10.1192/bjp.191.50.s71.
Cohen A, Patel V, Thara R, Gureje O (2008). „Questioning an axiom: better prognosis for schizophrenia in the developing world?”. Schizophr Bull. 34 (2): 229—44. PMC 2632419 . PMID 17905787. doi:10.1093/schbul/sbm105.
Burns J. (2009). „Dispelling a myth: developing world poverty, inequality, violence and social fragmentation are not good for outcome in schizophrenia”. Afr J Psychiatry (Johannesbg). 12 (3): 200—5. PMID 19894340. doi:10.4314/ajpsy.v12i3.48494.
Palmer BA, Pankratz VS, Bostwick JM (2005). „The lifetime risk of suicide in schizophrenia: a reexamination”. Archives of General Psychiatry. 62 (3): 247—53. PMID 15753237. doi:10.1001/archpsyc.62.3.247.
Carlborg A, Winnerbäck K, Jönsson EG, Jokinen J, Nordström P (2010). „Suicide in schizophrenia”. Expert Rev Neurother. 10 (7): 1153—64. PMID 20586695. doi:10.1586/ern.10.82.
De Leon J, Diaz FJ (2005). „A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors”. Schizophrenia Research. 76 (2–3): 135—57. PMID 15949648. doi:10.1016/j.schres.2005.02.010.
Keltner NL, Grant JS (2006). „Smoke, Smoke, Smoke That Cigarette”. Perspectives in Psychiatric Care. 42 (4): 256—261. PMID 17107571. doi:10.1111/j.1744-6163.2006.00085.x.
Castle D, Wessely S, Der G, Murray RM (1991). „The incidence of operationally defined schizophrenia in Camberwell, 1965–84”. The British Journal of Psychiatry. 159: 790—4. PMID 1790446. doi:10.1192/bjp.159.6.790.
Kumra S, Shaw M, Merka P, Nakayama E, Augustin R (2001). „Childhood-onset schizophrenia: research update”. Canadian Journal of Psychiatry. 46 (10): 923—30. PMID 11816313.
Jablensky, Sartorius & Ernberg 1992, стр. 1–97 Jablensky, A.; Sartorius, N.; Ernberg, G.; et al. (1992). „Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study”. Psychological Medicine Monograph Supplement. 20: 1—97. PMID 1565705. doi:10.1017/S0264180100000904.
Kirkbride, J. B.; Fearon, P.; Morgan, C.; et al. (2006). „Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study”. Archives of General Psychiatry. 63 (3): 250—8. PMID 16520429. doi:10.1001/archpsyc.63.3.250.
Kirkbride, J. B.; Fearon, P.; Morgan, C.; et al. (2007). „Neighbourhood variation in the incidence of psychotic disorders in Southeast London”. Social Psychiatry and Psychiatric Epidemiology. 42 (6): 438—45. PMID 17473901. doi:10.1007/s00127-007-0193-0.
Heinrichs, R. W. (2003). „Historical origins of schizophrenia: two early madmen and their illness”. Journal of the History of the Behavioral Sciences. 39 (4): 349—63. PMID 14601041. doi:10.1002/jhbs.10152.
Kuhn, R. (2004). tr. Cahn CH. „Eugen Bleuler's concepts of psychopathology”. History of Psychiatry. 15 (3): 361—6. PMID 15386868. doi:10.1177/0957154X04044603.
Stotz-Ingenlath G (2000). „Epistemological aspects of Eugen Bleuler's conception of schizophrenia in 1911” (PDF). Medicine, Health Care and Philosophy. 3 (2): 153—9. PMID 11079343. doi:10.1023/A:1009919309015.
Turner, T. (2007). „Unlocking psychosis”. British Medical Journal. 334 (suppl): s7. PMID 17204765. doi:10.1136/bmj.39034.609074.94.
Wing, J. K. (1971). „International comparisons in the study of the functional psychoses”. British Medical Bulletin. 27 (1): 77—81. PMID 4926366. doi:10.1093/oxfordjournals.bmb.a070819.
Rosenhan, D. (1973). „On being sane in insane places”. Science. 179 (4070): 250—8. Bibcode:1973Sci...179..250R. PMID 4683124. doi:10.1126/science.179.4070.250.
Wilson, M. (1993). „DSM-III and the transformation of American psychiatry: a history”. American Journal of Psychiatry. 150 (3): 399—410. PMID 8434655. doi:10.1176/ajp.150.3.399.
Stotz-Ingenlath G (2000). „Epistemological aspects of Eugen Bleuler's conception of schizophrenia in 1911”. Med Health Care Philos. 3 (2): 153—159. PMID 11079343. doi:10.1023/A:1009919309015.
Kim Y, Berrios GE (2001). „Impact of the term schizophrenia on the culture of ideograph: the Japanese experience”. Schizophr Bull. 27 (2): 181—5. PMID 11354585.
Sato, M. (2004). „Renaming schizophrenia: a Japanese perspective”. World Psychiatry. 5 (1): 53—55. PMC 1472254 . PMID 16757998.
Wu, E. Q. (2005). „The economic burden of schizophrenia in the United States in 2002”. Journal of Clinical Psychiatry. 66 (9): 1122—9. PMID 16187769.
Maniglio, R (март 2009). „Severe mental illness and criminal victimization: a systematic review”. Acta Psychiatrica Scandinavica. 119 (3): 180—91. PMID 19016668. doi:10.1111/j.1600-0447.2008.01300.x.
Fazel, S; Gulati, G; Linsell, L; Geddes, JR; Grann, M (август 2009). McGrath, John, ур. „Schizophrenia and Violence: Systematic Review and Meta-Analysis”. PLoS medicine. 6 (8): e1000120. PMC 2718581 . PMID 19668362. doi:10.1371/journal.pmed.1000120.
Large, M; Smith, G; Nielssen, O. (јул 2009). „The relationship between the rate of homicide by those with schizophrenia and the overall homicide rate: a systematic review and meta-analysis”. Schizophrenia research. 112 (1–3): 123—9. PMID 19457644. doi:10.1016/j.schres.2009.04.004.
Bo, S; Abu-Akel,, A.; Kongerslev, M; Haahr, UH; Simonsen, E (јул 2011). „Risk factors for violence among patients with schizophrenia”. Clinical Psychology Review. 31 (5): 711—26. PMID 21497585. doi:10.1016/j.cpr.2011.03.002.
Pescosolido BA, Monahan J, Link BG, Stueve A, Kikuzawa S (1999). „The public's view of the competence, dangerousness, and need for legal coercion of persons with mental health problems”. American Journal of Public Health. 89 (9): 1339—45. PMC 1508769 . PMID 10474550. doi:10.2105/AJPH.89.9.1339.

nimh.nih.gov

„Recovery After an Initial Schizophrenia Episode (RAISE) - National Institute of Mental Health (NIMH)”. www.nimh.nih.gov (на језику: енглески). Приступљено 2024-02-04.

oup.com (Global: 485^th place; Serbian: 495^th place)

academic.oup.com

Montagnese, Marcella; Leptourgos, Pantelis; Fernyhough, Charles; Waters, Flavie; Larøi, Frank; Jardri, Renaud; McCarthy-Jones, Simon; Thomas, Neil; Dudley, Rob (2021-01-23). „A Review of Multimodal Hallucinations: Categorization, Assessment, Theoretical Perspectives, and Clinical Recommendations”. Schizophrenia Bulletin (на језику: енглески). 47 (1): 237—248. ISSN 0586-7614. doi:10.1093/schbul/sbaa101.
Kohler, C. G.; Walker, J. B.; Martin, E. A.; Healey, K. M.; Moberg, P. J. (2010-09-01). „Facial Emotion Perception in Schizophrenia: A Meta-analytic Review”. Schizophrenia Bulletin (на језику: енглески). 36 (5): 1009—1019. ISSN 0586-7614. doi:10.1093/schbul/sbn192.

psychiatrictimes.com (Global: 9,815^th place; Serbian: low place)

Bottas, A. (15. 4. 2009). „Comorbidity: Schizophrenia With Obsessive-Compulsive Disorder”. Psychiatric Times. 26 (4).

psychiatryonline.org (Global: 4,032^nd place; Serbian: 2,550^th place)

psychiatryonline.org

Murante, Tessa; Cohen, Carl I. (2017). „Cognitive Functioning in Older Adults With Schizophrenia”. FOCUS (на језику: енглески). 15 (1): 26—34. ISSN 1541-4094. doi:10.1176/appi.focus.20160032.

ajp.psychiatryonline.org

McGurk SR, Mueser KT, Feldman K, Wolfe R, Pascaris A (2007). „Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial.”. American Journal of Psychiatry. 164 (3): 437—41. PMID 17329468. doi:10.1176/appi.ajp.164.3.437. Архивирано из оригинала 03. 03. 2007. г. Приступљено 03. 06. 2014.

rcpsych.org (Global: low place; Serbian: 8,720^th place)

bjp.rcpsych.org

Arseneault L, Cannon M, Witton J, Murray RM (2004). „Causal association between cannabis and psychosis: examination of the evidence”. Br J Psychiatry. 184 (2): 110—7. PMID 14754822. doi:10.1192/bjp.184.2.110.

revmed.ch (Global: low place; Serbian: low place)

Klaus, Federica; Dorsaz, Orianne; Kaiser, Stefan (2018). „Symptômes négatifs de la schizophrénie – état des lieux et implications pratiques”. Revue Médicale Suisse (на језику: енглески). 14 (619): 1660—1664. ISSN 1660-9379. doi:10.53738/REVMED.2018.14.619.1660.

sagepub.com (Global: 731^st place; Serbian: 793^rd place)

journals.sagepub.com

Bozikas, Vasilis P.; Andreou, Christina (2011). „Longitudinal Studies of Cognition in First Episode Psychosis: A Systematic Review of the Literature”. Australian & New Zealand Journal of Psychiatry (на језику: енглески). 45 (2): 93—108. ISSN 0004-8674. doi:10.3109/00048674.2010.541418.

springer.com (Global: 274^th place; Serbian: 510^th place)

link.springer.com

Hashimoto, Kenji (2019). „Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings”. Current Psychiatry Reports (на језику: енглески). 21 (8). ISSN 1523-3812. doi:10.1007/s11920-019-1063-7.

stanleylab.org (Global: low place; Serbian: low place)

Yolken R. (2004). „Viruses and schizophrenia: a focus on herpes simplex virus.”. Herpes. 11 (Suppl 2): 83A—88A. PMID 15319094.

web.archive.org (Global: 1^st place; Serbian: 1^st place)

„"Psychosis and schizophrenia in adults: treatment and management"” (PDF). март 2014. стр. 4—34. Архивирано из оригинала (PDF) 20. 04. 2014. г. (PDF). National Institute for Health and Care Excellence (NICE).. Archived from the original (PDF) on 20 April 2014.
Os, Jim van; Kapur, S. (август 2009). „Schizophrenia” (PDF). Lancet. 374 (9690): 635—45. PMID 19700006. doi:10.1016/S0140-6736(09)60995-8. Архивирано из оригинала (PDF) 23. 6. 2013. г. Приступљено 3. 6. 2014.
Association, American Psychiatric (2000). „Schizophrenia”. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Publishing, Inc. ISBN 978-0-89042-024-9. Архивирано из оригинала 11. 06. 2008. г. Приступљено 4. 7. 2008.
Kirkbride, JB; Jones, PB (март 2011). „The Prevention of Schizophrenia—What Can We Learn From Eco-Epidemiology?”. Schizophrenia bulletin. 37 (2): 262—71. PMC 3044619 . PMID 20974748. doi:10.1093/schbul/sbq120. Архивирано из оригинала 24. 4. 2012. г. Приступљено 3. 6. 2014.
McGurk SR, Mueser KT, Feldman K, Wolfe R, Pascaris A (2007). „Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial.”. American Journal of Psychiatry. 164 (3): 437—41. PMID 17329468. doi:10.1176/appi.ajp.164.3.437. Архивирано из оригинала 03. 03. 2007. г. Приступљено 03. 06. 2014.
Ruddy R, Milnes D (2005). „Art therapy for schizophrenia or schizophrenia-like illnesses.”. Cochrane Database Syst Rev (4): CD003728. PMID 16235338. doi:10.1002/14651858.CD003728.pub2. Архивирано из оригинала 27. 10. 2011. г. Приступљено 03. 06. 2014.
Ruddy RA, Dent-Brown K (2007). „Drama therapy for schizophrenia or schizophrenia-like illnesses.”. Cochrane Database Syst Rev (1): CD005378. PMID 17253555. doi:10.1002/14651858.CD005378.pub2. Архивирано из оригинала 25. 08. 2011. г. Приступљено 03. 06. 2014.

who.int (Global: 195^th place; Serbian: 154^th place)

„The ICD-10 Classification of Mental and Behavioural Disorders” (pdf). World Health Organization. стр. 26.
„Schizophrenia”. World Health Organization. 2011. Приступљено 27. 2. 2011.

wiley.com (Global: 222^nd place; Serbian: 155^th place)

onlinelibrary.wiley.com

Green, Michael F.; Horan, William P.; Lee, Junghee (2019). „Nonsocial and social cognition in schizophrenia: current evidence and future directions”. World Psychiatry (на језику: енглески). 18 (2): 146—161. ISSN 1723-8617. doi:10.1002/wps.20624.

worldcat.org (Global: 5^th place; Serbian: 12^th place)

Stępnicki, Piotr; Kondej, Magda; Kaczor, Agnieszka A. (2018-08-20). „Current Concepts and Treatments of Schizophrenia”. Molecules (на језику: енглески). 23 (8): 2087. ISSN 1420-3049. doi:10.3390/molecules23082087.
Marshall, Max; Lewis, Shon; Lockwood, Austin; Drake, Richard; Jones, Peter; Croudace, Tim (2005-09-01). „Association Between Duration of Untreated Psychosis and Outcome in Cohorts of First-Episode Patients: A Systematic Review”. Archives of General Psychiatry (на језику: енглески). 62 (9): 975. ISSN 0003-990X. doi:10.1001/archpsyc.62.9.975.
Montagnese, Marcella; Leptourgos, Pantelis; Fernyhough, Charles; Waters, Flavie; Larøi, Frank; Jardri, Renaud; McCarthy-Jones, Simon; Thomas, Neil; Dudley, Rob (2021-01-23). „A Review of Multimodal Hallucinations: Categorization, Assessment, Theoretical Perspectives, and Clinical Recommendations”. Schizophrenia Bulletin (на језику: енглески). 47 (1): 237—248. ISSN 0586-7614. doi:10.1093/schbul/sbaa101.
Klaus, Federica; Dorsaz, Orianne; Kaiser, Stefan (2018). „Symptômes négatifs de la schizophrénie – état des lieux et implications pratiques”. Revue Médicale Suisse (на језику: енглески). 14 (619): 1660—1664. ISSN 1660-9379. doi:10.53738/REVMED.2018.14.619.1660.
Klaus, Federica; Kaiser, Stefan; Kirschner, Matthias (2018). „Negativsymptome der Schizophrenie – ein Überblick”. Therapeutische Umschau (на језику: немачки). 75 (1): 51—56. ISSN 0040-5930. doi:10.1024/0040-5930/a000966.
Murante, Tessa; Cohen, Carl I. (2017). „Cognitive Functioning in Older Adults With Schizophrenia”. FOCUS (на језику: енглески). 15 (1): 26—34. ISSN 1541-4094. doi:10.1176/appi.focus.20160032.
Bozikas, Vasilis P.; Andreou, Christina (2011). „Longitudinal Studies of Cognition in First Episode Psychosis: A Systematic Review of the Literature”. Australian & New Zealand Journal of Psychiatry (на језику: енглески). 45 (2): 93—108. ISSN 0004-8674. doi:10.3109/00048674.2010.541418.
Biedermann, Falko; Fleischhacker, W. Wolfgang (2016). „Psychotic disorders in DSM-5 and ICD-11”. CNS Spectrums (на језику: енглески). 21 (4): 349—354. ISSN 1092-8529. doi:10.1017/S1092852916000316.
Hashimoto, Kenji (2019). „Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings”. Current Psychiatry Reports (на језику: енглески). 21 (8). ISSN 1523-3812. doi:10.1007/s11920-019-1063-7.
Javitt, Daniel C.; Sweet, Robert A. (2015). „Auditory dysfunction in schizophrenia: integrating clinical and basic features”. Nature Reviews Neuroscience (на језику: енглески). 16 (9): 535—550. ISSN 1471-003X. doi:10.1038/nrn4002.
Goldberg, Terry E; Keefe, Richard S E; Goldman, Robert S; Robinson, Delbert G; Harvey, Philip D (2010). „Circumstances Under Which Practice Does Not Make Perfect: A Review of the Practice Effect Literature in Schizophrenia and Its Relevance to Clinical Treatment Studies”. Neuropsychopharmacology (на језику: енглески). 35 (5): 1053—1062. ISSN 0893-133X. doi:10.1038/npp.2009.211.
Green, Michael F.; Horan, William P.; Lee, Junghee (2019). „Nonsocial and social cognition in schizophrenia: current evidence and future directions”. World Psychiatry (на језику: енглески). 18 (2): 146—161. ISSN 1723-8617. doi:10.1002/wps.20624.
Kohler, C. G.; Walker, J. B.; Martin, E. A.; Healey, K. M.; Moberg, P. J. (2010-09-01). „Facial Emotion Perception in Schizophrenia: A Meta-analytic Review”. Schizophrenia Bulletin (на језику: енглески). 36 (5): 1009—1019. ISSN 0586-7614. doi:10.1093/schbul/sbn192.
Grill-Spector, Kalanit; Weiner, Kevin S.; Kay, Kendrick; Gomez, Jesse (2017-09-15). „The Functional Neuroanatomy of Human Face Perception”. Annual Review of Vision Science (на језику: енглески). 3 (1): 167—196. ISSN 2374-4642. doi:10.1146/annurev-vision-102016-061214.
Häfner, Heinz (2019-04-16). „From Onset and Prodromal Stage to a Life-Long Course of Schizophrenia and Its Symptom Dimensions: How Sex, Age, and Other Risk Factors Influence Incidence and Course of Illness”. Psychiatry Journal (на језику: енглески). 2019: 1—15. ISSN 2314-4327. doi:10.1155/2019/9804836.

yimg.com (Global: low place; Serbian: low place)

xa.yimg.com

Os, Jim van; Kapur, S. (август 2009). „Schizophrenia” (PDF). Lancet. 374 (9690): 635—45. PMID 19700006. doi:10.1016/S0140-6736(09)60995-8. Архивирано из оригинала (PDF) 23. 6. 2013. г. Приступљено 3. 6. 2014.

Шизофренија (Serbian Wikipedia)

academia.edu (Global: 121st place; Serbian: 30th place)

cambridge.academia.edu

annualreviews.org (Global: 3,867th place; Serbian: 3,436th place)

archive.org (Global: 6th place; Serbian: 5th place)

behavenet.com (Global: low place; Serbian: 6,565th place)

books.google.com (Global: 3rd place; Serbian: 2nd place)

brown.uk.com (Global: low place; Serbian: low place)

cambridge.org (Global: 305th place; Serbian: 325th place)

cochrane.org (Global: 7,609th place; Serbian: 9,992nd place)

doi.org (Global: 2nd place; Serbian: 4th place)

dsm5.org (Global: low place; Serbian: 2,943rd place)

elsevier.com (Global: 610th place; Serbian: 653rd place)

linkinghub.elsevier.com

elsevierhealth.com (Global: low place; Serbian: low place)

download.journals.elsevierhealth.com

emedicine.com (Global: 3,595th place; Serbian: 3,106th place)

harvard.edu (Global: 18th place; Serbian: 28th place)

adsabs.harvard.edu

hindawi.com (Global: 6,828th place; Serbian: 9,104th place)

hogrefe.com (Global: low place; Serbian: low place)

econtent.hogrefe.com

jamanetwork.com (Global: 2,650th place; Serbian: 3,845th place)

archpsyc.jamanetwork.com

kluweronline.com (Global: low place; Serbian: low place)

mdpi.com (Global: 2,912th place; Serbian: 8,753rd place)

nature.com (Global: 234th place; Serbian: 287th place)

nice.org.uk (Global: 3,258th place; Serbian: 1,880th place)

nih.gov (Global: 4th place; Serbian: 8th place)

ncbi.nlm.nih.gov

nimh.nih.gov

oup.com (Global: 485th place; Serbian: 495th place)

academic.oup.com

psychiatrictimes.com (Global: 9,815th place; Serbian: low place)

psychiatryonline.org (Global: 4,032nd place; Serbian: 2,550th place)

psychiatryonline.org

ajp.psychiatryonline.org

rcpsych.org (Global: low place; Serbian: 8,720th place)

bjp.rcpsych.org

revmed.ch (Global: low place; Serbian: low place)

sagepub.com (Global: 731st place; Serbian: 793rd place)

journals.sagepub.com

springer.com (Global: 274th place; Serbian: 510th place)

link.springer.com

stanleylab.org (Global: low place; Serbian: low place)

web.archive.org (Global: 1st place; Serbian: 1st place)

who.int (Global: 195th place; Serbian: 154th place)

wiley.com (Global: 222nd place; Serbian: 155th place)

onlinelibrary.wiley.com

worldcat.org (Global: 5th place; Serbian: 12th place)

yimg.com (Global: low place; Serbian: low place)

xa.yimg.com

academia.edu (Global: 121^st place; Serbian: 30^th place)

annualreviews.org (Global: 3,867^th place; Serbian: 3,436^th place)

archive.org (Global: 6^th place; Serbian: 5^th place)

behavenet.com (Global: low place; Serbian: 6,565^th place)

books.google.com (Global: 3^rd place; Serbian: 2^nd place)

cambridge.org (Global: 305^th place; Serbian: 325^th place)

cochrane.org (Global: 7,609^th place; Serbian: 9,992^nd place)

doi.org (Global: 2^nd place; Serbian: 4^th place)

dsm5.org (Global: low place; Serbian: 2,943^rd place)

elsevier.com (Global: 610^th place; Serbian: 653^rd place)

emedicine.com (Global: 3,595^th place; Serbian: 3,106^th place)

harvard.edu (Global: 18^th place; Serbian: 28^th place)

hindawi.com (Global: 6,828^th place; Serbian: 9,104^th place)

jamanetwork.com (Global: 2,650^th place; Serbian: 3,845^th place)

mdpi.com (Global: 2,912^th place; Serbian: 8,753^rd place)

nature.com (Global: 234^th place; Serbian: 287^th place)

nice.org.uk (Global: 3,258^th place; Serbian: 1,880^th place)

nih.gov (Global: 4^th place; Serbian: 8^th place)

oup.com (Global: 485^th place; Serbian: 495^th place)

psychiatrictimes.com (Global: 9,815^th place; Serbian: low place)

psychiatryonline.org (Global: 4,032^nd place; Serbian: 2,550^th place)

rcpsych.org (Global: low place; Serbian: 8,720^th place)

sagepub.com (Global: 731^st place; Serbian: 793^rd place)

springer.com (Global: 274^th place; Serbian: 510^th place)

web.archive.org (Global: 1^st place; Serbian: 1^st place)

who.int (Global: 195^th place; Serbian: 154^th place)

wiley.com (Global: 222^nd place; Serbian: 155^th place)

worldcat.org (Global: 5^th place; Serbian: 12^th place)